Study of Motesanib (AMG 706) in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer

Clinical trial NCT02629848 · TERMINATED

Trial details

NCT number: NCT02629848
Sponsor: Takeda
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2012-07-01
Primary completion: 2014-09-01
Enrollment: 401

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.